Decreased dromotropic response to verapamil despite pronounced increased drug concentration in rheumatoid arthritis

British Journal of Clinical Pharmacology

Volumn 50, Issue 6, 2000, Pages 605-613

  Mayo, Patrick R ^a   Skeith, Kenneth ^a   Russell, Anthony S ^a   Jamali, Fakhreddin ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Dromotropic response; Rheumatoid arthritis; Verapamil

Indexed keywords

INTERLEUKIN 6; NITRIC OXIDE; VERAPAMIL;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG BINDING; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG RESPONSE; FEMALE; HUMAN; LIVER BLOOD FLOW; MALE; PHARMACODYNAMICS; PR INTERVAL; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RHEUMATOID ARTHRITIS;

ADULT; AREA UNDER CURVE; ARTHRITIS, RHEUMATOID; CALCIUM CHANNEL BLOCKERS; FEMALE; HUMANS; INTERLEUKIN-6; MALE; METABOLIC CLEARANCE RATE; NITRITES; VERAPAMIL;

EID: 0034536649     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.2000.00314.x     Document Type: Article

References (59)

1. Effect of inflammatory disease on plasma concentrations of three β-adrenoreceptor blocking agents
2. Influence of endotoxin on the steroselective pharmacokinetics of oxprenolol, propranolol, and verapamil in the rat
3. Effect of turpentine-induced inflammation on the disposition kinetics of propranolol, metoprolol, and antipyrine in the rat
4. Selective effect of adjuvant arthritis on the disposition of propranolol enantiomers in rats detected using a stereospecific HPLC assay
5. Effect of adjuvant arthritis on the disposition of acebutolol enantiomers in rats
6. Adverse drug reactions of DMARRs and DC-ARTs in rhematoid arthritis
7. Adverse drug reactions in patients with rheumatoid arthritis and HLA-DR3
8. Penicillamine
9. Chairman round table discussion-proper use of penicillamine
10. Antagonism of antihypertensive drug therapy by nonsteroidal anti-inflammatory drugs
11. Nonsteroidal anti-inflammatory drugs and antihypertensives
12. Inflammatory status as a main determinant of outcome in patients with unstable angina, independent of coagulation activation and endothelial cell function
13. Binding of β-adrenoreceptor blocking drugs to human serum albumin, to α1-acid-glycoprotein and to human serum
14. The metabolism of DL-[14C]verapamil in man
15. Identification of P450 enzymes involved in metabolism of verapamil in humans
16. Cytochrome P450 isoforms involved in metabolism of the enantiomers of verapamil and norverapamil
17. Cardiac dysrhythmias in severe verapamil overdose: Characterization with a canine model
18. Systemic availability of oral verapamil and effect on PR interval in man
19. NSAIDs and blood pressure. Clinical importance for older patients
20. Simultaneous direct determination of the enantiomers of verapamil and norverapamil in plasma using a derivatized amylose HPLC chiral stationary phase
21. Measurement of nitrate and nitrite in extracellular fluids: A Window to systemic nitric oxide metabolism
22. Verapamil protein binding in patients and normal subjects
23. Understanding the dose-effect relationship: Clinical application of pharmacokinetic-pharmacodynamic models
24. The effect of dextro-, levo-, and racemic verapamil on atrioventricular conduction in humans
25. Clearance approaches in pharmacology
26. Clinical pharmacokinetics, concepts and applications
27. Regulation of acute phase gene expression by inflammatory mediators
28. Adjuvant induced arthritis and drug-metabolizing enzymes
29. Immunomodulating agents and hepetic drug metabolizing enzymges
30. Kupfer cell factor mediated depression of hepatic parenchymal cell cytochrome P-450
31. Verapamil plasma binding: Relationship to α1-acid glycoprotein and drug efficacy
32. Stereoselective protein binding of verapamil enantiomers
33. Gut wall metabolism of verapamil in older people: Effects of rifampicin-mediated enzyme induction
34. Stereoselective verapamil disposition and dynamics in aging during racemic verapamil administration
35. Effect of experimental diabetes mellitus and arthritis on the pharmacokinetics of hydroxychloroquine enantiomers in rats
36. Influence of severity of inflammation on the disposition kinetics of propranolol enantiomers in ketoprofen treated and untreated adjuvant arthritis
37. Acute-phase reponse, IL-6 and alteration of cyclosporin pharmacokinetics
38. Cytokines dow-regulate expression of major cytochrome P450 enzymes in adult human hepatocytes in primary culture
39. Nitric oxide is a mediator of the decrease in CYP450-dependent metabolism caused by immunostimulants
40. Cytokines and cytokine inhibitors oral antagonists in rheumatoid arthritis
41. Increased nitric oxide levels in patients with rheumatoid arthritis
42. Lipid mediators, active oxygen, amines, nitric oxide, kinins and clotting factors in rheumatoid arthritis
43. Regulation of hepatic blood flow during resuscitation from hemorrhagic shock. Role of NO and endothelins
44. Autoregulation of renal and splanchnic blood flow following infra-renal aortic clamping is mediated by nitric oxide and vasodilator prostanoids
45. Mechanism responsible for altered propranolol disposition in adjuvant-induced arthritis in the rat
46. Effects of d,l-verapamil on atrioventricular conduction in relation to its stereoselective first-pass metabolism
47. Electrophysiological effects of verapamil metabolites in the isolated heart
48. Influence of metabolites on protein binding of verapamil
49. The nitric oxide-cGMP signal transduction system for intracellular and intercellular communication
50. Negative inotropic effects of cytokines on the heart mediated by nitric oxide
51. Decreased density of beta-adrenergic receptors on peripheral blood mononuclear cells in patients with rheumatoid arthritis
52. Regulation of the beta-receptor-adenylate cyclase system in lymphocytes of allergic patients with asthma: Possible role for protein kinase C in allergen-induced nonspecific refractoriness of adenylate cyclase
53. Altered inotropism in the failing human myocardium
54. The beta-adrenergic receptor kinase: Role in homologous desensitization in S49 lymphoma cells
55. Verapamil decreases lymphocyte protein kinase C activity in humans
56. Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow-up in patients under thrombolytic treatment